Lansdale, PA, United States of America

Douglas W Hobbs

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas W Hobbs. Retrieved from https://idiyas.com/inventor/douglas-w-hobbs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Douglas W. Hobbs

Introduction

Douglas W. Hobbs is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of tocolytic oxytocin receptor antagonists. His work has the potential to impact maternal health and pregnancy management.

Latest Patents

Douglas W. Hobbs holds 1 patent for his invention related to tocolytic oxytocin receptor antagonists. This patent represents a crucial advancement in the medical field, offering new avenues for treatment.

Career Highlights

Hobbs is currently employed at Merck & Company, Inc., a leading global healthcare company. His role at Merck allows him to collaborate with other talented professionals in the industry, driving innovation and research forward.

Collaborations

Some of his notable coworkers include Ben E. Evans and Joseph M. Pawluczyk. Their collective expertise contributes to the success of their projects and enhances the research environment at Merck.

Conclusion

Douglas W. Hobbs exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of tocolytic oxytocin receptor antagonists, highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…